|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cyclooxygenase-2: a novel target for cancer chemotherapy显示文摘 | Dempke W Rie C Grothey A | 2001 | J Cancer Res Clin Oncol2001，127，7： | 1 |
| 2 | Evidence for cure by adju- vant therapy in colon cancer: observations based on individual pa- tient data from 20,898 patients on 18 randomized trials显示文摘 | Sargent D Sobrero A Grothey A | 2009 | J Clin Oncol2009，27，6： | 1 |
| 3 | Intravenous calcium and magnesium for oxaliplatin-induced sensory neurntoxicity in adjuvant colon cancer: NCCTG N04C7 显示文摘 | Grothey A Nikcevich DA Sloan JA | 2011 | Journal of Clinical Oncology2011，29，4： | 1 |
| 4 | Randomized phase 1I trial of capecitabine plus irinotecan(Caplri) vscapecitabine plus oxaliplatin (CapOx) as first-line therapy of advanced colorectal cancer(ACRC) 显示文摘 | Grothey A Jordan K Keller O | 2003 | Proc Am Soc Clin Oncol2003，22，： | 1 |
| 5 | Regorafenibmonotherapy for previously treated metastatic colorectalcancer (CORRECT): an international, multicentre,ran-domised, placebo- controlled, phase 3 trial 显示文摘 | Grothey A Cutsem EV Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 6 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, ran- domised, placebo-controlled, phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 7 | Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates显示文摘 | Folprecht G Grothey A Alberts S | 2005 | Ann 0ncol2005，16，8： | 1 |
| 8 | Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study(BRITE)显示文摘 | Grothey A Sugrue MM Purdie DM | | 0，，26： | 1 |
| 9 | Surgical resection after downsizing of colorecta] liver metastasis in the era of bevacizumah 显示文摘 | Ellis LM Curley SA Grothey A | 2005 | J Clin Oncol2005，23，22： | 1 |
| 10 | Human hematopoietic growth factors:old lesson and new perspectives显示文摘 | DEMPKE W VON POBLOZKI GROTHEY A | 2000 | Anticancer Res2000，20，60： | 1 |
| 11 | Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20898 patients on 18 randomized trials 显示文摘 | Sargent DJ Sobrero A Grothey A | 2009 | J Clin Oncol2009，27，6： | 1 |
| 12 | Developments in combination chemotherapy for colorectal cancer 显示文摘 | Goetz MP Grothey A | 2004 | Expert Rev Anticancer Ther2004，4，4： | 1 |
| 13 | Cyclooxygenase-2: a novel target for cancer chemotherapy? 显示文摘 | Dempke W Rie C Grothey A | 2001 | J Cancer Res Clin Oncol2001，127，7： | 1 |
| 14 | A meta-analysis comparing the efficacy of four 5-HT3-reeeptor antagonists for acute chemotherapy-induced emesis 显示文摘 | Jordan K Hinke A Grothey A | 2007 | Support Care Cancer2007，15，9： | 1 |
| 15 | Cyclooxygenase-2:a novel target for cancer chemotherapy显示文摘 | Dempke W Rie C Grothey A | 2001 | J Cancer Res Clin Oncol2001，127，7： | 1 |
| 16 | C-erbB-2/HER-2 upregulates fascin,an actin-bundling protein associated with cell motility,in human breast cancer cell lines显示文摘 | GROTHEY A HASHIZUME R JI H | 2000 | Oncogene2000，19，42： | 1 |
| 17 | Cyclooxygenase-2:a novel target for cancer chemotherapy显示文摘 | Dempke W Rie C Grothey A | 2001 | J Cancer Res Clin Oncol2001，127，7： | 1 |
| 18 | Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line 显示文摘 | Grothey A Sargent D | 2005 | J Clin Oncol2005，23，36： | 1 |
| 19 | Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7 显示文摘 | Grothey A Nikcevich DA Sloan JA | 2011 | Journal of Clinical Oncology2011，29，4： | 1 |
| 20 | I ntravenous Calcium and Magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer:NCCTG N04C7显示文摘 | GROTHEY A NIKCEVICH D A SLOAN J A | 2011 | Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology2011，29，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员